Skip to content
Screener

DBV Technologies DBVT Total Current Assets

Total Current Assets at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$407.93M+254%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$341.97M+23.9%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$130.18M+46.0%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$724.93M+11.8%
Alumis Inc. logo
Alumis Inc.ALMS
$532.41M+136%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$589.04M+156%

Other financials

Income statement

See full
Revenue$700.0K-53.3%
Operating income-$50.6M-23.1%
Net income-$50.4M-20.3%
EPS (diluted)-$0.12+61.3%

Balance sheet

See full
Cash & equivalents$174.9M+69.5%
Total debt$7.7M+0.1%
Total equity$160.4M+86.1%
Total assets$223.2M+55.6%

Cash flow

See full
Operating cash flow-$52.6M-55.2%
CapEx$400.0K
Free cash flow-$53.0M-56.3%

Valuation

See full
Market cap$847.16M+218%
Enterprise value$679.96M+297%
P/S168.8×+100×

Profitability

See full
Operating margin-3,543.1%+523pp
Net margin-3,506.5%+442pp
FCF margin-3,399.3%+3,268pp

Returns & leverage

See full
Return on equity-142.7%-5.0pp
Debt / equity0.0×
Current ratio3.7×+1.3×

Where this comes from

Reported directly by DBV Technologies in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: DBV Technologies’s 10-Q, filed July 16, 2026.

Filed
Jul 16, 2026, 4:08 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-048453
Line itemNoteJune 30, 2026December 31, 2025
Current assets :
Cash and cash equivalents3174.9194.2
Other current assets527.018.8
Total current assets201.9212.9
Property, plant, and equipment, net49.710.4
Right-of-use assets65.94.6
Other non-current assets55.85.8
Total non-current assets21.320.8

Item 1C. Condensed Consolidated Statements of Financial Position (Unaudited) as of

FAQ

What is DBV Technologies's total current assets?
DBV Technologies (DBVT) reported total current assets of $201.9M in Q2 2026.
How has DBV Technologies's total current assets changed year-over-year?
DBV Technologies's total current assets increased by 66.5% year-over-year, from $121.24M to $201.9M.
What is the long-term trend for DBV Technologies's total current assets?
Over 5 years (2020 to 2025), DBV Technologies's total current assets has grown at a 0.5% compound annual growth rate (CAGR), from $207.38M to $212.9M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about DBV Technologies's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude